click below
click below
Normal Size Small Size show me how
BDK ID #3-4
Basic Drug Knowledge Infectious Diseases Page #3-4
| Generic Name | Brand Name | Classification | Pharmacologic Category | Common Indications | Activity Against | Key Side Effects | US Boxed Warnings | Other Notes |
|---|---|---|---|---|---|---|---|---|
| Clindamycin (PO, IV) | Cleocin | Lincosamide Antibiotic | Skin & Soft Tissue Infection (SSTI), Pharyngitis | MRSA (Methicillin-Resistant Staphylococcus Aureus)/MSSA (Methicillin-Susceptible Staphylococcus Aureus), Streptococcus Species, Anaerobes | Diarrhea, Clostridioides Difficile Diarrhea | Clostridioides difficile-associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including clindamycin, & may range in severity from mild diarrhea to fatal colitis | ||
| Sulfamethoxazole & Trimethoprim (PO, IV) | Bactrim, Bactrim DS | Sulfonamide Antibiotic | Skin & Soft Tissue Infection (SSTI), Cystitis, Pyelonephritis, Opportunistic Infection Prophylaxis | MRSA (Methicillin-Resistant Staphylococcus Aureus), Enterobacteriaceae | Nausea, Vomiting, Diarrhea, Skin Rashes (Rarely SJS [Stevens-Johnson syndrome] or TEN [Toxic Epidermal Necrolysis], Photosensitivity, Crystalluria, Hyperkalemia, Increased Serum Creatinine, Hypersensitivity Reactions | |||
| Nitrofurantoin (PO) | Macrobid | Urinary Antibiotic | Cystitis | Escherichia Coli | Nausea, Pulmonary Fibrosis (Chronic Use) | |||
| Fosfomycin (PO) | Monurol | Urinary Antibiotic | Cystitis | Escherichia Coli | Headache, Diarrhea, Nausea | |||
| Tobramycin (IV, Inhaled) | Tobi (Inhaled) | Aminoglycoside Antibiotic | Hospital-Acquired Pneumonia (HAP), Cystic Fibrosis (Nebulized Only) | Escherichia Coli, Pseudomonas Aeruginosa | Nephrotoxicitiy, Ototoxicity | |||
| Vancomycin (IV, PO) | Vancocin | Glycopeptide Antibiotic | IV: Skin & Soft Tissue Infection (SSTI), Hospital-Acquired Pneumonia (HAP), Meningitis, Endocarditis, Catheter-Related Blood Stream Infection (CRBSI) PO: Clostridioides Difficile Infection (CDI) | MRSA (Methicillin-Resistant Staphylococcus Aureus), Clostridioides Difficile (PO Only) | Nephroxtoxicity, Vancomycin Infusion Reaction, Ototoxicity | |||
| Metronidazole (PO, IV) | Flagyl | Antibiotic | Anaerobic Infections, Clostridioides Difficile Infection (CDI) | Bacteroides Species, Clostridioides Difficile | Nausea, Metallic Taste, Disulfiram Reaction with Alcohol, Peripheral Neuropathy (Long-Term Use) | |||
| Mupirocin (Topical) | Bactroban | Antibiotic | Methicillin-Resistant Staphylococcus Aureus (MRSA) Decolonization | No Major Side Effects | ||||
| Neomycin + Polymyxin B + Bacitracin (Topical, Ophthalmic) | Topical: Neosporin Ophthalmic: Neo-Polycin | Neosporin: OTC | Topical Antibiotic | Topical Infection Prevention, Ocular Infections | Reddening, Itching | |||
| Terbinafine (PO, Topical) | Lamisil | Topical: OTC | Allylamine Antifungal | Onychomycosis | Nausea, Abdominal Pain, Diarrhea, Elevated Hepatic Transaminases, Headache | |||
| Fluconazole (PO, IV) | Diflucan | Azole Antifungal | Vulvovaginal Candidiasis, Oropharyngeal Candidiasis, Invasive Candidiasis | Nausea, Abdominal Pain, Diarrhea, QTc Prolongation, Elevated Hepatic Transaminases | ||||
| Ketoconazole (PO, Topical) | Nizoral | Topical: OTC | Azole Antifungal | Tinea Infections | Nausea, Abdominal Pain, Diarrhea, QTc Prolongation, Elevated Hepatic Transaminases | Serious hepatotoxicity, including cases with a fatal outcome or requiring liver transplanation have occurred; May cause QTc prolongation & drug interactions leading to QTc prolongation | ||
| Nystatin (PO) | --- | Polyene Antifungal | Oropharyngeal Candidiasis | Phlebitis, Diarrhea, Vomiting, Anemia, Fever | ||||
| Nystatin (Topical) | Nystop | Polyene Antifungal | Cutaneous & Mucocutaneous Fungal Infections | Burning, Itching | Only use oral solutions for thrush | |||
| Micafungin (IV) | Mycamine | Echinocandin Antifungal | Invasive Candidiasis | No Major Side Effects | ||||
| Betamethasone & Clotrimazole (Topical) | Lotrisone | Glucocorticoid & Azole Antifungal | Cutaneous Fungal Infections | Burning, Itching, Dryness, Skin Atrophy | Do not use for diaper dermatitis; Adrenal suppresion with long-term use over large areas of skin | |||
| Oseltamivir (PO) | Tamiflu | Neuraminidase Inhibitor Antiviral | Influenza | Nausea, Vomiting, Neuropsychiatric Events (i.e., Confusion, Delirium, Hallucinations) in Pediatric Patients (Rare) | ||||
| Acyclovir (PO, IV) | Zovirax | Antiviral | Herpes Simplex Virus | Nausea, Increased Hepatic Transaminases, Crystalluria | Vesicant | |||
| Valacyclovir (PO) | Valtrex | Antiviral | Herpes Simplex Virus | Nausea, Increased Hepatic Transaminases | ||||
| Nirmatrelvir + Ritonavir (PO) | Paxlovid | Antiviral | COVID-19 | Diarrhea, Dysgeusia | Significant drug interactions; Strong CYP3A inhibitor | |||
| Remdesivir (IV) | Veklury | Antiviral | COVID-19 | Hyperglycemia, Renal Impairment, Bradycardia, Increased Liver Enzymes, Hypersensitivity | ||||
| Emtricitabine + Tenofovir Disoproxil Fumarate (PO) | Truvada | Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI) | Human Immunodeficiency Virus (HIV) Infection, Preexposure Prophylaxis (PreP), Postexposure Prophylaxis (PEP) | Decreased Bone Mineral Density, Kidney Injury, Nausea, Diarrhea | Post treatment acute exacerbation of hepatitis B, Risk of drug resistance with use for preexposure prophylaxis | |||
| Emtricitabine (NRTI) + Tenofovir Alafenamide (NRTI) + Bictegravir (INSTI) (PO) | Biktarvy | Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI) & Integrase Strand Transfer Inhibitor (INSTI) | Human Immunodeficiency Virus (HIV) Infection | Increased Serum Bilirubin, Headache, Weight Gain, Insomnia, Diarrhea, Nausea | Post treatment acute exacerbation of hepatitis B | Take oral INSTIs 2 hours before or 6 hours after products containing calcium, aluminum, magnesium, or iron |